Stocks Explorer
Stocks
Sectors
Search
Takeda Pharmaceutical Company Limited(TAKP34) News
Profile
Chart
News
Analysis
TAKP34 price today
by TradingView
Date
Title
Jan 16
U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
‹ Prev
Page
of 1
Next ›